# Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation

> **NCT04844814** · PHASE2 · SUSPENDED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 204 (estimated)

## Conditions studied

- Gout
- Chronic Kidney Disease
- Renal Transplantation

## Interventions

- **DRUG:** Anakinra 100Mg/0.67Ml Inj Syringe
- **DRUG:** Prednisone
- **DRUG:** Placebo of Prednisone
- **DRUG:** Placebo of Anakinra

## Key facts

- **NCT ID:** NCT04844814
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-06-02
- **Primary completion:** 2025-02-12
- **Final completion:** 2026-08-31
- **Target enrollment:** 204 (ESTIMATED)
- **Why stopped:** Peremption of treatments, difficulty of patients recrutment (28 patients in 3 years) and lack of funding to pursue the study.
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04844814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04844814, "Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04844814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*